CDT Equity Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CDT Nasdaq 2830 www.conduitpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CDT Equity Inc.

CDT Equity Inc. Announces Reverse Stock Split - Oct 9th, 2025 6:00 am
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy - Aug 26th, 2025 6:30 am
Conduit to Change Name to CDT Equity Inc. - Aug 5th, 2025 6:30 am
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health - Jun 4th, 2025 6:30 am
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - May 22nd, 2025 6:30 am
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - May 21st, 2025 6:30 am
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - May 16th, 2025 6:30 am
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - May 9th, 2025 6:30 am
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset - May 8th, 2025 6:30 am
Conduit Pharmaceuticals Announces Leadership Changes - Apr 16th, 2025 6:30 am
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects - Apr 11th, 2025 6:30 am
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program - Apr 10th, 2025 6:30 am
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization - Apr 7th, 2025 6:30 am
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - Mar 31st, 2025 6:30 am
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904 - Mar 19th, 2025 6:30 am
Is Conduit Pharmaceuticals Inc. (CDT) the Best Micro Cap Stock to Buy Now? - Mar 7th, 2025 2:53 am
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel - Mar 6th, 2025 7:35 am
Conduit Progresses Phase II of its AI Initiative with Sarborg - Feb 20th, 2025 6:00 am
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model - Feb 13th, 2025 6:00 am
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note - Feb 11th, 2025 7:00 am